Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
J Intern Med ; 270(1): 65-75, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21198993

RESUMEN

OBJECTIVES: We compared the ability of very high levels of nonfasting cholesterol and triglycerides to predict risk of myocardial infarction and total mortality. DESIGN: Prospective study from 1976 to 1978 until 2007. SETTING: Danish general population. PARTICIPANTS: Randomly selected population of 7581 women and 6391 men, of whom 768 and 1151 developed myocardial infarction and 4398 and 4416 died, respectively. Participation rate was 72%, and follow-up was 100% complete. Less than 2% of participants were taking lipid-lowering therapy. RESULTS: Compared to women with cholesterol <5 mmol L(-1) , multivariate-adjusted hazard ratios for myocardial infarction ranged from 1.3 [95% confidence interval (CI): 0.9-1.8] for a cholesterol level of 5.0-5.99 mmol L(-1) to 2.5 (95%CI: 1.6-4.0) for cholesterol ≥ 9 mmol L(-1) (trend: P < 0.0001). Compared with women with nonfasting triglycerides <1 mmol L(-1) , hazard ratios for myocardial infarction ranged from 1.5 (95%CI: 1.2-1.8) for triglycerides of 1.0-1.99 mmol L(-1) to 4.2 (95%CI: 2.5-7.2) for triglycerides ≥ 5 mmol L(-1) (p<0.0001). In men, corresponding hazard ratios ranged from 1.2 (95%CI: 1.0-1.5) to 5.3 (95%CI: 3.6-8.0) for cholesterol (P < 0.0001) and from 1.3 (95%CI: 1.0-1.6) to 2.1 (95%CI: 1.5-2.8) for triglycerides (P < 0.0001). Increasing cholesterol levels were not consistently associated with total mortality in women (trend: P = 0.39) or men (P = 0.02). By contrast, compared with women with triglycerides <1 mmol L(-1) , multivariate-adjusted hazard ratios for total mortality ranged from 1.1 (95%CI: 1.0-1.2) for triglycerides of 1.0-1.99 mmol L(-1) to 2.0 (95%CI: 1.5-2.9) for triglycerides ≥5 mmol L(-1) (trend: P < 0.0001); corresponding hazard ratios in men ranged from 1.1 (95%CI: 1.0-1.2) to 1.5 (95%CI: 1.2-1.7) (P < 0.0001). CONCLUSIONS: Stepwise increasing levels of nonfasting cholesterol and nonfasting triglycerides were similarly associated with stepwise increasing risk of myocardial infarction, with nonfasting triglycerides being the best predictor in women and nonfasting cholesterol the best predictor in men. Even more surprisingly, only increasing levels of nonfasting triglycerides were associated with total mortality, whereas increasing cholesterol levels were not.


Asunto(s)
Colesterol/sangre , Infarto del Miocardio/sangre , Triglicéridos/sangre , Adulto , Biomarcadores/sangre , Dinamarca/epidemiología , Métodos Epidemiológicos , Femenino , Humanos , Hipercolesterolemia/complicaciones , Hipercolesterolemia/epidemiología , Masculino , Persona de Mediana Edad , Infarto del Miocardio/epidemiología , Infarto del Miocardio/etiología , Isquemia Miocárdica/epidemiología , Isquemia Miocárdica/etiología , Factores Sexuales
2.
J Thromb Haemost ; 8(8): 1694-701, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20456754

RESUMEN

BACKGROUND: Atherosclerosis is an inflammatory condition where cysteinyl leukotrienes have been identified to play an important role. Furthermore, cysteinyl leukotrienes may also affect thrombus formation. Using prospective, cross-sectional and case-control designs, we tested the hypothesis that hitherto unknown genetic variation, likely to affect the function of leukotriene C(4) synthase, is associated with risk of venous thromboembolism, ischemic stroke and myocardial infarction. METHODS AND RESULTS: Resequencing the gene coding for leukotriene C(4) synthase in an extreme risk population with more than 1500 individuals revealed 17 new mutations, of which four are likely to change protein function (211G>A (minor allele frequency, 0.0001), IVS3 + 1G>A (0.002), 374G>A (0.0006) and 451_453+10del (0.0007)). Based on genotyping 50,000 individuals, age and sex adjusted odds ratios for venous thromboembolism were 2.0 (95% CI, 1.3-3.5) for IVS3+1G>A heterozygotes vs. wild type, and 1.9 (1.5-2.7) for any mutation heterozygote vs. wild type. Corresponding values were 2.0 (1.3-3.2) and 1.5 (1.1-2.1) for ischemic stroke, and 1.0 (0.8-1.3) and 1.2 (1.0-1.4) for myocardial infarction. CONCLUSIONS: Four novel mutations that are likely to change the function of leukotriene C(4) synthase were associated with increased risk of venous thromboembolism and ischemic stroke. These findings need confirmation in other independent studies. In addition, the mechanism behind these findings deserves further investigation.


Asunto(s)
Enfermedades Cardiovasculares/genética , Glutatión Transferasa/genética , Mutación , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Estudios Transversales , Dinamarca , Femenino , Predisposición Genética a la Enfermedad , Variación Genética , Genotipo , Heterocigoto , Humanos , Isquemia/patología , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Estudios Prospectivos , Factores de Riesgo , Factores Sexuales , Accidente Cerebrovascular/patología
3.
Curr Drug Targets ; 10(4): 328-35, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19355857

RESUMEN

Most humans are in the nonfasting or postprandial state in the majority of a 24 hour cycle; however, lipids, lipoproteins, and apolipoproteins are usually measured in the fasting state. Recent studies demonstrate that these values at most change minimally in response to normal food intake, changes that are clinically unimportant. Also, elevated levels of nonfasting triglycerides as a marker of elevated remnant lipoprotein cholesterol associate strongly with increased risk of myocardial infarction, ischemic stroke, and early death. The mechanism behind these findings likely involves entrance of remnant lipoproteins into the arterial intima with subsequent retention leading to atherogenesis, while low HDL cholesterol levels may be an innocent bystander. Finally, nonfasting levels of total cholesterol, non-HDL cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, HDL cholesterol, apolipoprotein A1, total cholesterol/HDL cholesterol, and apolipoprotein B/apolipoprotein A1 all associate with increased risk of cardiovascular disease. These new data open the possibility that nonfasting rather than fasting lipid profiles can be used for cardiovascular risk prediction. If implemented, this would simplify blood sampling for lipid measurements for millions of patients worldwide. Furthermore, the results also highlight the need for randomized double-blind trials of new and established drugs to reduce nonfasting triglycerides and remnant lipoprotein cholesterol, with the ultimate aim of reducing risk of cardiovascular disease and early death.


Asunto(s)
Enfermedades Cardiovasculares/sangre , Ayuno/sangre , Hiperlipidemias/sangre , Animales , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/prevención & control , Pruebas Hematológicas/métodos , Humanos , Hiperlipidemias/diagnóstico , Hiperlipidemias/prevención & control , Factores de Riesgo
4.
Int J Cardiovasc Imaging ; 17(5): 361-70, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12025950

RESUMEN

Increased regional myocardial 18F fluorodeoxyglucose (18FDG) uptake in relation to 13N ammonia (13NH3) uptake--i.e. glucose metabolism-blood flow 'mismatch'--appears to be a strong indicator of myocardial viability in patients with ischemic heart disease (IHD) and regionally reduced contractile function. Reference values of regional 18FDG and 13NH3 uptake have not been determined in healthy subjects with the target age for the development of IHD. We therefore studied healthy middle-aged and old men using positron emission tomography (PET). Twenty-three healthy men aged 51 to 83 years of age were studied. 18FDG and 13NH3 uptake was quantified in 16 myocardial segments with PET and circumferential profile analysis. The relative 18FDG/13NH3 uptake was considerably heterogeneous with 18FDG uptake consistently higher than 13NH3 uptake in the left lateral ventricular wall. This regional 'mismatch' pattern was observed in all subjects, but was most prominent in middle-aged men. The observed age-dependency was the result of a progressive increased in 13NH3 uptake with advancing age in the left ventricular lateral wall. Age-matched reference values of myocardial 18FDG and 13NH3 uptake appears to be important for the discrimination between physiological and pathological glucose metabolism-blood flow mismatch assessed by PET and circumferential profile analysis.


Asunto(s)
Amoníaco/metabolismo , Fluorodesoxiglucosa F18/metabolismo , Miocardio/metabolismo , Tomografía Computarizada de Emisión , Anciano , Anciano de 80 o más Años , Envejecimiento/fisiología , Dinamarca , Humanos , Masculino , Persona de Mediana Edad , Valores de Referencia , Estadística como Asunto
5.
Except Child ; 58(6): 530-40, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1592079

RESUMEN

This investigation was designed to change teacher-student interactions in middle school social studies and science classes. Eighteen of 35 teacher volunteers received a six-session inservice emphasizing teacher effectiveness variables. Results indicated significant differences between experimental and control teachers on a pre-post contrast, as well as on a follow-up (maintenance) contrast. Differential effects on the science and social studies teachers were seen. Similarities and differences related to student type, independent of the intervention, were obtained.


Asunto(s)
Integración Escolar , Competencia Profesional , Relaciones Profesional-Paciente , Ciencia , Niño , Curriculum , Humanos , Refuerzo en Psicología
6.
J Assoc Off Anal Chem ; 72(6): 881-2, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2687224

RESUMEN

A new colorimetric method is described for the determination of enzymatic activity of subtilisin in cleaning products. The procedure is more rapid and precise than the casein digestion methods commonly used to assay protease activity. The principle of the colorimetric method depends on the determination rate of p-nitrophenol released on hydrolysis of N-CBZ-L-leucine-p-nitrophenyl ester at pH 8.0 by subtilisin, with correction for any nonenzymatic (spontaneous) hydrolysis of the substrate. Because of the broad range of hydrolytic activity of this enzyme, and the difficulties in predicting its proteolytic activity, this hydrolytic rate was chosen as a general indicator of subtilisin enzyme behavior. The slope for 7 replicate standard curves generated over a 6 week period exhibited a relative standard deviation of 7.5%, and 8.0% for 20 replicates with an enzyme cleaning product. Papain does not interfere with this assay.


Asunto(s)
Jabones/análisis , Subtilisinas/análisis , Tensoactivos/análisis , Caseínas/metabolismo , Colorimetría , Espectrofotometría Ultravioleta
7.
Am J Physiol ; 252(1 Pt 2): R40-7, 1987 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3028167

RESUMEN

The streptozotocin-induced diabetic rat was used to test the hypothesis that Na+-H+ exchange activity in the proximal tubule luminal membrane would be increased in association with renal hypertrophy, altered glomerular hemodynamics, enhanced filtered load and tubular reabsorption of Na+, and stimulated Na+ pump activity in the basolateral membrane, previously reported characteristics of this experimental animal model. Amiloride-sensitive H+ gradient-dependent Na+ uptake and Na+ gradient-dependent H+ flux were increased in brush-border membrane vesicles from the streptozotocin-treated animals. Na+ gradient-dependent uptakes of phosphate, D-glucose, L-proline, and myoinositol were decreased in the drug-induced diabetic animals. These membrane transport alterations were not found when the streptozotocin-diabetic animals were treated with insulin.


Asunto(s)
Proteínas Portadoras/metabolismo , Diabetes Mellitus Experimental/fisiopatología , Riñón/fisiopatología , Animales , Transporte Biológico/efectos de los fármacos , Tasa de Filtración Glomerular , Concentración de Iones de Hidrógeno , Corteza Renal/metabolismo , Masculino , Microvellosidades/metabolismo , Tamaño de los Órganos , Ratas , Ratas Endogámicas , Sodio/farmacología , Intercambiadores de Sodio-Hidrógeno
8.
Metabolism ; 34(3): 199-204, 1985 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3883094

RESUMEN

The effects of chromic chloride (CrCl3) administered orally for 12 weeks to five elderly subjects with glucose intolerance were assessed. Pretreatment and posttreatment, the hyperglycemic clamp technique was employed to determine glucose utilization, beta-cell sensitivity to glucose, and tissue sensitivity to insulin. In addition, erythrocyte insulin binding was studied. Urinary chromium excretion increased approximately 5 fold indicating good compliance with supplementation. The oral glucose tolerance curves following supplementation were lowered from 60 to 120 minutes but only the 60-minute values were significantly lowered. In agreement with this was significantly increased glucose utilization during the hyperglycemic clamp studies. Tissue sensitivity to insulin, receptor affinity, and total insulin binding were unchanged by supplementation while beta-cell sensitivity to glucose increased following supplementation (P less than 0.04), and explained the increased glucose utilization. HDL and LDL and total cholesterol levels were slightly lower after chromium supplementation, but no change reached statistical significance. The LDL/HDL cholesterol ratio was unchanged. This study shows small but statistically significant effects of CrCl3 on carbohydrate metabolism. The clinical relevance of these effects, that is, their prophylactic or therapeutic significance, remains to be determined.


Asunto(s)
Cloruros , Compuestos de Cromo , Cromo/uso terapéutico , Hiperglucemia/tratamiento farmacológico , Anciano , Envejecimiento , Glucemia , Colesterol/sangre , Cromo/orina , Evaluación de Medicamentos , Femenino , Humanos , Insulina/metabolismo , Masculino , Persona de Mediana Edad , Receptor de Insulina/efectos de los fármacos , Receptor de Insulina/metabolismo
9.
Am J Physiol ; 248(2 Pt 2): F233-9, 1985 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-3970213

RESUMEN

Administration of the synthetic glucocorticoid dexamethasone to adrenalectomized rats increased Na+/H+ exchange activity in isolated renal brush border membrane vesicles. Treatment altered the initial rate of Na+ uptake by increasing Vmax (19.90 +/- 2.17 vs. 27.32 +/- 1.50 nmol.mg protein-1.5 s-1) and not the apparent affinity KNa+ (8.33 +/- 1.11 vs. 7.94 +/- 1.60 mM). Dexamethasone treatment resulted in a proportional increase in 1 mM Na+ uptake at every intravesicular pH measured. When these data were analyzed by the Hill equation, it was found that dexamethasone treatment did not change the apparent number of H+ binding sites (1.24 vs. 1.26) or the [H+]0.5 (0.33 vs. 0.32 microM) but increased the apparent Vmax (0.98 vs. 0.55 nmol.mg protein-1.2 s-1). It was also found that dexamethasone injections of 60 micrograms/100 g body wt resulted in maximum stimulation of exchange activity and that a significant increase in amiloride-sensitive Na+ uptake was detected within 12 h after a single dose of dexamethasone.


Asunto(s)
Dexametasona/farmacología , Hidrógeno/metabolismo , Corteza Renal/metabolismo , Sodio/metabolismo , Adrenalectomía , Aldosterona/farmacología , Amilorida/farmacología , Animales , Relación Dosis-Respuesta a Droga , Intercambio Iónico , Cinética , Masculino , Microvellosidades/metabolismo , Ratas , Ratas Endogámicas , Factores de Tiempo
11.
Proc Natl Acad Sci U S A ; 79(16): 4932-6, 1982 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-6956901

RESUMEN

The glucocorticoid dexamethasone, but not the mineralocorticoid aldosterone, increased amiloride-sensitive Na+-H+ exchange activity in rat proximal tubule brush border vesicles. Na+ uptake, independent of amiloride, was not affected. The glucocorticoid decreased the Na+ gradient-dependent phosphate uptake. Uptake in the absence of a Na+ gradient was not inhibited. Dexamethasone did not affect the Na+ gradient-dependent D-glucose uptake. These findings are consistent with the effects of glucocorticoids in stimulating acid secretion and causing phosphaturia in man and animals and may identify the locus of action and suggest the mechanisms by which the hormones act.


Asunto(s)
Glucocorticoides/farmacología , Concentración de Iones de Hidrógeno , Corteza Renal/metabolismo , Fosfatos/metabolismo , Sodio/fisiología , Aldosterona/farmacología , Amilorida/farmacología , Animales , Transporte Biológico Activo/efectos de los fármacos , Sistema Libre de Células , Dexametasona/farmacología , Glucosa/metabolismo , Masculino , Microvellosidades/metabolismo , Ratas
12.
J Biol Chem ; 256(18): 9731-6, 1981 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-6270099

RESUMEN

The possible role of cyclic AMP-mediated phosphorylation events in the regulation of exocrine secretion after beta-adrenergic stimulation was examined in vitro in dispersed acinar cell aggregates from rat parotid gland. l-Isoproterenol, a beta-adrenergic agonist, stimulated endogenous activity of cyclic AMP-dependent protein kinase, alterations in the 32P content of 3 parotid phosphoproteins (increased 32P in 2, Mr = 27,000 and 14,000; decreased 32P in the remaining, Mr = 13,600), and amylase secretion in a dose-dependent manner. All responses were half-maximal within a range of l-isoproterenol concentrations of approximately 4 X 10(-8) to 5 X 10(-7) M. Examination of the time course of these 3 processes revealed that by 30 s after addition of l-isoproterenol, significant elevations in cyclic AMP-dependent protein kinase activity and alterations in the 32P content of the 3 parotid proteins had occurred, whereas secretion of amylase from cells was first detected 1-2 1/2 min after hormonal stimulation. Dibutyryl cyclic AMP (2 mM) elicited the same changes in parotid protein 32P content as l-isoproterenol. Our results support the concept of a role for cyclic AMP-regulated protein phosphorylation in the sequence of cellular events leading to exocrine protein secretion from the rat parotid gland following beta-adrenergic stimulation.


Asunto(s)
Glándula Parótida/metabolismo , Fosfoproteínas/metabolismo , Proteínas Quinasas/metabolismo , Receptores Adrenérgicos beta/fisiología , Receptores Adrenérgicos/fisiología , Animales , Bucladesina/farmacología , AMP Cíclico/metabolismo , Activación Enzimática , Isoproterenol/farmacología , Cinética , Masculino , Peso Molecular , Glándula Parótida/citología , Fosforilación , Ratas , Ratas Endogámicas
19.
Dtsch Med Wochenschr ; 100(44): 2252-6, 2261-4, 1975 Oct 31.
Artículo en Alemán | MEDLINE | ID: mdl-1183322

RESUMEN

Urine obtained simultaneously by midstream voiding and supra-public bladder aspiration from 500 patients were compared by bacteriological and, in some, microscopic examination. In a second series a similar examination was undertaken on 1000 samples each, obtained by midstream voiding, catheterisation or suprapublic bladder aspiration from different patients. There was no significant difference in sediments or Stansfeld count between midstream and aspirated samples. Qualitative false-positive results for protein were obtained in 20% of midstream samples from women. The Kass count for significant bacteriuria was false-positive in 3.4% of midstream compared with bladder-aspiration samples, in 7.6% for "questionable bacteriuria". Positive counts of under 10(5)/ml were obtained in 41.3%, of under 10(4)/ml in 26.7% of aspirated samples. Counts under 10(4)/ml in midstream-voided samples are usually considered the result of contamination, at times falsely so. "Mixed infections" were 7.8 times more common in catheter and 11.4 to 11.8 times more common in midstream than in aspirated samples. The presence of microorganisms in suprapublic bladder aspiration is always abnormal. Chemotherapy is indicated only on results from bladder aspiration.


Asunto(s)
Bacteriuria/diagnóstico , Punciones , Vejiga Urinaria , Bacteriuria/microbiología , Femenino , Humanos , Masculino , Punciones/métodos , Cateterismo Urinario , Micción
20.
Circ Res ; 36(6 Suppl 1): 125-32, 1975 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1132074

RESUMEN

Peripheral plasma renin activity (PRA) is not invariably elevated in patients whose ischemic renal lesion is causing hypertension. Infusions of an angiotensin II antagonist, 1-sar-8-ala-angiotensin II (P-113), have been used to determine whether the blood pressure responses might indicate angiotensin dependence in 221 consecutive hypertensive patients. In 32 patients P-113 infusion reversibly reduced blood pressure, and almost all of these "P-113 responders" had elevated renal vein and/or peripheral PRA levels, together with evidence of renal ischemia. Among the 189 "P-113 nonresponders," peripheral PRA was elevated in seven (3.8%), and renal vein PRA ratio was abnormal in two patients, who might represent exceptions to the otherwise successful record of the P-113 response in identifying "angiotensinoginic" hypertensives.


Asunto(s)
Angiotensina II/análogos & derivados , Hipertensión/diagnóstico , Saralasina , Adulto , Anciano , Angiografía , Angiotensina II/biosíntesis , Presión Sanguínea/efectos de los fármacos , Humanos , Hipertensión/sangre , Hipertensión/etiología , Isquemia/fisiopatología , Riñón/irrigación sanguínea , Persona de Mediana Edad , Nefrectomía , Renografía por Radioisótopo , Flujo Sanguíneo Regional , Venas Renales , Renina/sangre , Saralasina/farmacología , Urografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA